Ortho-McNeil Pharmaceutical Inc. intends to appeal the decision granting Caraco Pharmaceutical Laboratories Ltd.’s motion for summary judgment on Ortho-McNeil’s reissue patent, according to the Company’s latest Form 10-Q filed with…
The 30-month stay in the RAZADYNE(R) cases filed by Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., expires in late August 2008.
In the action against Barr Laboratories, Inc. and AlphaPharm with…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., intends to appeal the summary judgment decision invalidating the claims of U.S. Patent No. 39,221 (reissue patent).
The ‘221 patent claims combinations of acetaminophen…
The Court of Appeals for the Federal Circuit, on July 21, 2008, affirmed the decision upholding the enforceability of the patent on ACIPHEX(R), according to Johnson & Johnson’s Form 10-Q…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., continues to be in a dispute with Sandoz Inc. over its challenges to the RAZADYNE(R) ER patents.
In the action against Sandoz with respect…
The Federal District Court in Delaware has yet to issue its ruling in Ortho-McNeil Pharmaceutical Inc.’s CONCERTA(R) patent suit against Andrx Corporation.
Ortho-McNeil is a Johnson & Johnson subsidiary.
In the action…
Settlement discussions between Johnson & Johnson’s subsidiary, Ortho Women’s Health & Urology, and Barr Laboratories, Inc. regarding the ORTHO TRICYCLEN(R) LO patent are still underway.
Ortho Women’s is a Division of…